22 Oct Catalent Biologics to expand Madison operations, add 100 jobs
Catalent Pharma Solutions, a publicly traded, Somerset, New Jersey company, will expand its Madison operations, hiring more than 100 additional employees over the next two years.
Catalent Biologics Madison will build more than 22,000 square feet of manufacturing, office and laboratory space at its 726 Heartland Trail site, on the Far West Side, in a $34 million project scheduled to start construction in November.
The company, currently at 145 employees in Madison, makes investigational drugs.
“Our Madison, Wisconsin facility is a state-of-the-art biologics manufacturing facility,” Brian C. Riley, general manager of the Madison site, said in an email. “We use our multiple proprietary technologies to develop and manufacture novel biopharmaceutical therapies.”
Sorry, the comment form is closed at this time.